- Home
- PFX vs OKYO Comparison
PFX vs OKYO Comparison
Compare PFX & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFX | OKYO |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 79.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | PFX | OKYO |
|---|---|---|
| Price | $44.33 | $1.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 1.1K | ★ 184.4K |
| Earning Date | 12-12-2025 | 07-18-2025 |
| Dividend Yield | ★ 3.29% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | ★ $25,262,322.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.09 | ★ N/A |
| Revenue Growth | ★ 13.89 | N/A |
| 52 Week Low | $41.00 | $0.90 |
| 52 Week High | $57.40 | $3.35 |
Technical Indicators
Market Signals| Indicator | PFX | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 43.72 |
| Support Level | $41.50 | $1.90 |
| Resistance Level | $42.00 | $2.40 |
| Average True Range (ATR) | 0.60 | 0.20 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 100.00 | 29.29 |
Price Performance
Historical ComparisonAbout PFX PhenixFIN Corporation
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.